Innovation Pharmaceuticals Inc (IPIX)

[nerby]

You don't need a million dollars to know the answer to that question, though there are millions to be made (or lost) once the question is answered. IPIX gave you the answer 3 weeks ago, on Thanksgiving.

"In just a few short weeks, we will be convening our Brilacidin-Oral Mucositis End-of-Phase 2 regulatory meeting. Success here not only would help us to complete development of the drug, but also to advance other aspects of our clinical pipeline."

Hard to be more clear than that. It's a binary event coming up. The victory - or the defeat - precedes the battle.